Kidney injury, stem cells and regeneration

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 1, 2014, Pages 25-31

  Humphreys, Benjamin D ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

directed differentiation; kidney stem cell; mesenchymal stem cell; regeneration; reprogramming

Indexed keywords

CD133 ANTIGEN; CD24 ANTIGEN; G PROTEIN COUPLED RECEPTOR; KIDNEY INJURY MOLECULE 1; PLACEBO; VIMENTIN;

ACUTE KIDNEY FAILURE; CELL DEDIFFERENTIATION; EMBRYONIC STEM CELL; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY REGENERATION; MESENCHYMAL STEM CELL; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; UPREGULATION; WNT SIGNALING PATHWAY;

ACUTE KIDNEY INJURY; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HUMANS; KIDNEY; REGENERATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84890559152     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000437332.31418.e0     Document Type: Review

References (60)

1. Little MH, McMahon AP. Mammalian kidney development: Principles, progress, and projections. Cold Spring Harb Perspect Biol 2012; 4:1-18.
2. Herzlinger D, Koseki C, Mikawa T, et al. Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development 1992; 114:565-572.
3. Kobayashi A, Valerius MT, Mugford JW, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008; 3:169-181.
4. Boyle S, Misfeldt A, Chandler KJ, et al. Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia. Dev Biol 2008; 313:234-245.
5. Cuppage FE, Neagoy DR, Tate A. Repair of the nephron following temporary occlusion of the renal pedicle. Lab Invest 1967; 17:660-674.
6. Witzgall R, Brown D, Schwarz C, et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994; 93:2175-2188.
7. Guo JK, Cantley LG. Cellular maintenance and repair of the kidney. Annu Rev Physiol 2010; 72:357-376.
8. Elger M, Hentschel H, Litteral J, et al. Nephrogenesis is induced by partial nephrectomy in the elasmobranch Leucoraja erinacea. J Am Soc Nephrol 2003; 14:1506-1518.
9. Diep CQ, Ma D, Deo RC, et al. Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature 2011; 470:95-100.
10. Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009; 20:333-343.
11. Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009; 20:322-332.
12. Langworthy M, Zhou B, de Caestecker M, et al. NFATc1 identifies a population of proximal tubule cell progenitors. J Am Soc Nephrol 2009; 20:311-321.
13. Lindgren D, Bostrom AK, Nilsson K, et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 2011; 178:828-837.
14. Angelotti ML, Ronconi E, Ballerini L, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012; 30:1714-1725. This article provides strong evidence that human kidney contains a scattered population of CD24CD133 cells that contribute to repair after injury. When injected into severe combined immunodeficiency mice with AKI, these progenitors improved kidney function.
15. Kim K, Park BH, Ihm H, et al. Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Histol Histopathol 2011; 26:223-232.
16. Loverre A, Capobianco C, Ditonno P, et al. Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function. Transplantation 2008; 85:1112-1119.
17. Barker N, Rookmaaker MB, Kujala P, et al. Lgr5(ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Reports 2012; 2:540-552. This study used rigorous lineage tracing to show that during nephrogenesis, Lgr5 expression defines an intratubular progenitor population that contributes to differentiated cells in the thick ascending limb and connecting segment.
18. Kitamura S, Yamasaki Y, Kinomura M, et al. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J 2005; 19:1789-1797.
19. Gupta S, Verfaillie C, Chmielewski D, et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 2006; 17:3028-3040.
20. Maeshima A, Sakurai H, Nigam SK. Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol 2006; 17:188-198.
21. Challen GA, Bertoncello I, Deane JA, et al. Kidney side population reveals multilineage potential and renal functional capacity but also cellular heterogeneity. J Am Soc Nephrol 2006; 17:1896-1912.
22. Humphreys BD, Valerius MT, Kobayashi A, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2:284-291.
23. Vogetseder A, Palan T, Bacic D, et al. Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney. Am J Physiol Cell Physiol 2007; 292:C807-813.
24. Vogetseder A, Picard N, Gaspert A, et al. Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells. Am J Physiol Cell Physiol 2008; 294:C22-28.
25. Humphreys BD, Czerniak S, Dirocco DP, et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci U S A 2011; 108:9226-9231.
26. Romagnani P, Lasagni L, Remuzzi G. Renal progenitors: An evolutionary conserved strategy for kidney regeneration. Nature Rev Nephrol 2013; 9:137-146.
27. Romagnani P. Of mice and men: The riddle of tubular regeneration. J Pathol 2013; 229:641-644.
28. Smeets B, Boor P, Dijkman H, et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol 2013; 229:645-659.
29. Wallin A, Zhang G, Jones TW, et al. Mechanism of the nephrogenic repair response. Studies on proliferation and vimentin expression after 35S-1,2-dichlorovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial cells. Lab Invest 1992; 66:474-484.
30. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem1998; 273:4135-4142.
31. Bianco P, Cao X, Frenette PS, et al. The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 2013; 19:35-42.
32. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008; 59:311-325.
33. Bruno S, Grange C, Deregibus MC, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009; 20:1053-1067.
34. Tomasoni S, Longaretti L, Rota C, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 2013; 22:772-780. Direct demonstration that MSCs deliver mRNAs to injured epithelial cells via exosome-mediated mRNA transfer, including that of insulin-like growth factor-1 receptor.
35. Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289:F31-F42.
36. Wang Y, He J, Pei X, et al. Systematic review and meta-analysis of mesenchymal stem/stromal cells therapy for impaired renal function in small animal models. Nephrology (Carlton) 2013; 18:201-208.
37. Togel FE, Westenfelder C. Kidney protection and regeneration following acute injury: Progress through stem cell therapy. Am J Kidney Dis 2012; 60:1012-1022.
38. Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5:54-63.
39. Bi B, Schmitt R, Israilova M, et al. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007; 18:2486-2496.
40. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
41. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012; 481:295-305.
42. Cai J, Zhao Y, Liu Y, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007; 45:1229-1239.
43. Wichterle H, Lieberam I, Porter JA, et al. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002; 110:385-397.
44. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015-1024.
45. Yang YM, Gupta SK, Kim KJ, et al. A small molecule screen in stem-cellderived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 2013; 12:713-726. The first study to show that drugs can be validated in vitro using iPS-derived cell types and that the results may predict results in clinical trials, leading to the concept of 'in-vitro clinical trials'.
46. Kim YJ, Lee G. Candidate ALS therapeutics motor toward 'in vitro clinical trials'. Cell Stem Cell 2013; 12:633-634.
47. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005; 16:3527-3534.
48. Bruce SJ, Rea RW, Steptoe AL, et al. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation 2007; 75:337-349.
49. Vigneau C, Polgar K, Striker G, et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol 2007; 18:1709-1720.
50. Batchelder CA, Lee CC, Matsell DG, et al. Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation 2009; 78:45-56.
51. Song B, Smink AM, Jones CV, et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS One 2012; 7:e46453.
52. Davies JA, Unbekandt M, Ineson J, et al. Dissociation of embryonic kidney followed by re-aggregation as a method for chimeric analysis. Methods Mol Biol 2012; 886:135-146. This reviews a protocol for the most rigorous test of kidney progenitor function-their ability to incorporate into kidney structures after reaggregation with embryonic kidney progenitors in vitro.
53. Mae S, Shono A, Shiota F, et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun 2013; 4:1367-1373. The first comprehensive protocol for the directed differentiation of embryonic stem cells toward kidney fates. A strength of the study is the high efficiency with which the authors were able to induce intermediate mesoderm.
54. Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008; 455:627-632.
55. Hendry CE, Vanslambrouck JM, Ineson J, et al. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J Am Soc Nephrol 2013; 24:1424-1434. This is the first study to demonstrate direct reprogramming of one somatic cell type to a kidney fate. In this case, tubular epithelial cells were reprogrammed to nephron progenitors.
56. Hammerman MR. Tissue engineering the kidney. Kidney Int 2003; 63:1195-1204.
57. Humes HD, Buffington D, Westover AJ, et al. The bioartificial kidney: Current status and future promise. Pediatr Nephrol 2013. [Epub ahead of print]
58. Humes HD, Weitzel WF, Bartlett RH, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004; 66:1578-1588.
59. Tumlin J, Wali R, Williams W, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008; 19:1034-1040.
60. Song JJ, Guyette JP, Gilpin SE, et al. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013; 19:646-651.